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Gastric Xanthomatosis and Cholestasis 
A Causal Relationship 
A L L A N  G. COATES,  DO, T IMOTHY  T. NOSTRANT,  MD, J O A N N E  A.P. WILSON,  MD, 
W I L L I A M  O. DOBBINS,  III, MD, and FAROOQ P. AGHA,  MD 
We report two cases of  gastric xanthomatosis which developed in patients with marked 
cholestasis. In both cases, one with acute and one with chronic cholestasis, the gastric 
xanthomas disappeared with resolution of  the cholestasis. A review of  the literature is also 
provided. 
Xanthomatosis  is characterized by collections of 
lipid-laden macrophages,  or foam cells, forming 
plaques or nodules in many tissues, most  commonly 
the skin (1-3). Involvement  can occur  in all regions 
of  the gastrointestinal tract, but is most common in 
the stomach (2). Once thought to be a rare entity, 
gastric xanthomatosis  has been reported with in- 
creasing f requency with the advent of  increasing 
utilization of  gastrointestinal endoscopy (2, 4-8). 
Because gastric xanthomas appear to be more com- 
mon in patients with gastritis, gastric ulcer, and 
with duodenogastr ic  reflux after gastric surgery, 
mucosal  damage has been presumed to play a major 
role in their pathogenesis (2, 4 ;  6). Although cho- 
lesterol and neutral fat are the major constituents of 
the foam cells, there is no documented relationship 
between degree of  hyperlipidemia or hypercholes- 
terolemia and presence of gastric xanthomatosis.  
We report  two patients with marked xanthomatous 
infiltration of  the stomach which developed con- 
comitant with cholestasis and hypercholesterolemia 
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and disappeared with resolution of  the hyperlipid- 
emia. 
MATERIALS AND METHODS 
Case 1. C.S., a 36-year-old white female, was in good 
health until September 1972 when, at the age of 22, she 
developed intense pruritis and fatigue two weeks after 
starting oral contraceptives. At that time, her serum 
bilirubin was 2.0 rag/100 ml, SGOT 150 IU/liter, SGPT 
120 IU/liter, and alkaline phosphatase 680 IU/liter. After 
eight months of dietary treatment for "hepatitis," the 
patient was hospitalized for severe right upper quadrant 
pain. Her serum bilirubin was 4.6 mg/100 ml and an 
alkaline phosphatase was 600 IU/liter. Exploratory lapa- 
rotomy demonstrated a normal gallbladder and biliary 
tree. Wedge liver biopsy revealed cirrhosis with a paucity 
of bile ducts. In several portal areas, nonsuppurative 
destructive cholangitis with granulomas was also present. 
A cholecystectomy was performed, and the patient was 
discharged on prednisone 20 mg on alternate days. 
She was seen for the first time at the University of 
Michigan Medical Center in November 1976 with chief 
complaints of fatigue, numbness in the hands, and facial 
nodules. She had scleral icterus, extensive eruptive 
xanthomas, and hepatosplenomegaly. Her serum 
bilirubin was 8.2 mg/100 ml and alkaline phosphatase was 
1745 IU/liter. Antimitochondrial antibodies were present 
at a titer of 1:320, serum cholesterol was 2796 mg/100 ml, 
and triglycerides were 250 mg/100 ml. Endoscopic retro- 
grade cholangiography showed minor intrahepatic bile 
duct beading and extensive yellowish nodular and plaque- 
like lesions of the gastric mucosa (Figure 1). Biopsy from 
the gastric mucosa revealed normal fundic epithelium and 
marked infiltration of the lamina propria with foam cells 
(Figure 2). A diagnosis of primary biliary cirrhosis with 
gastric xanthomatosis was made. Prednisone was discon- 
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Fig 1. Massive lipid infiltration involving body and antrum of 
stomach in case 1. Both nodules (small arrow) and plaques (large 
arrow) are visible endoscopically. 
Fig 3. Endoscopic picture of plaquelike xanthomas (arrow) 
involving greater curve of stomach during acute cholestasis in 
case 2. 
Fig 2. Light microscopic photomicrograph of case 1 showing 
normal surface epithelium and marked infiltration of lamina 
propria by foamy macrophages (F). The macrophages were not 
stained by the PAS reaction. H&E stain, • 
tinued and plasmapheresis was begun for xanthomatous 
neuropathy. 
Despite improvement in her peripheral neuropathy, the 
patient was lost to follow-up until she presented with 
massive upper gastrointestinal bleeding in January 1984. 
her bilirubin was 22 rag/100 ml and alkaline phosphatase 
was 900 IU/liter. Serum cholesterol was 90 mg/100 ml, 
and triglycerides were 25 rag/100 ml. Upper gastrointes- 
tinal endoscopy revealed bleeding esophageal varices, 
but no gastric xanthomas. The patient died two days after 
admission. 
Case 2. S.E., a 21-year-old white female was well until 
November 1984 when she developed tonic clonic sei- 
zures. Diphenylhydantoin 100 mg three times a day was 
instituted after a negative neurological evaluation. Two 
weeks after beginning diphenylhydantoin, she developed 
a morbilliform rash and a temperature of 105 ~ F. Her 
admission serum bilirubin was 1.0 mg/100 ml, alkaline 
phosphatase 310 IU/liter, and SGOT 685 IU/liter. Hepa- 
titis serologies and antimitochondrial antibodies were 
negative. A presumptive diagnosis of diphenylhydantoin 
hepatotoxicity was made, and the drug was discontinued. 
Two weeks after admission, she improved sufficiently to 
be discharged. 
After discharge, cholestasis persisted and she devel- 
oped eruptive xanthomas of the fingers and palms. Serum 
cholesterol was 1610 rag/100 ml and triglycerides were 60 
mg/100 ml. Intractable pruritus and vomiting prompted a 
second hospital admission. Serum bilirubin was 7.3 
mg/100 ml, SGOT 145 IU/liter, and alkaline phosphatase 
2595 IU/liter. Ultrasound examination demonstrated a 
normal gallbladder and common bile duct size. Liver 
biopsy showed marked neocholangiolar proliferation. Eso- 
phagogastroduodenoscopy demonstrated yellow plaques 
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Fig 4. Light microscopic photomicrograph of case 2 showing 
normal surface epithelium and modest infiltration of lamina 
propria with foamy macyophages (F). H&E stain, • 
and nodules from the midbody of the stomach to the 
pylorus (Figure 3). Several nodules were seen in the 
duodenum. Biopsy specimens revealed the presence of 
foamy histiocytes in both the stomach (Figure 4) and 
duodenum. 
Over the next five months, her laboratory values nor- 
malized. Repeat endoscopy and biopsy specimens were 
normal (Figures 5 and 6). 
DISCUSSION 
Endoscopically, gastric xanthomas are yellow 
plaque-like or nodular lesions of variable size (1-6). 
They are found in the highest concentration in the 
prepyloric region along the lesser curvature, al- 
though they may be found anywhere in the stom- 
ach. The reported incidence of gastric xanthomas in 
autopsy series varies from 2% to 53% (1, 3). Endo- 
scopic studies show their incidence to be between 
I% and 4%. Histologically, gastric xanthomas are 
characterized by infiltration of the lamina propria 
by lipid-laden macrophages, often called foam cells. 
Other lamina propria cells may also be involved 
with lipid deposits. Chemical analysis has shown 
that the foam cells contain cholesterol with or 
without neutral fat (4). No association with 
Fig 5. Endoscopic picture demonstrating a normal mucosa along 
the greater curve of the stomach after resolution of cholestasis in 
case 2. 
hyperlipidemia or hypercholesterolemia has been 
reported to date (1). 
The cause of gastric xanthomas is unknown. The 
importance of damage to the gastric mucosa is 
pointed out by the fact that xanthomata largely 
appear in damaged gastric mucosa (1-6). The asso- 
ciation of xanthomas with gastric ulcers and 
gastritis has occasionally led to difficulties in differ- 
entiating this lesion on biopsy from infiltrative sig- 
net-cell carcinoma of the stomach. It has been 
postulated that chronic inflammation may cause 
focal mucosal damage. Repair of this damage leaves 
behind lipid-containing debris, which is eventually 
phagocytized by histiocytes forming foam cells (6). 
Domellof et al (6) found a high incidence of 
gastric xanthomas in patients who had subtotal 
gastrectomy for treatment of benign gastric ulcers. 
Gastric xanthomas were found in 6.3% of nonoper- 
ated controls and in 6.2% of patients one to three 
years after surgery. This incidence increased 
steadily to 60% twenty-three years after gastric 
surgery. No relation to patient age, lipid levels, or 
serum cholesterol was found. The stomal location 
of these lesions led Domellof et al to hypothesize 
that intestinal reflux with subsequent intestinal 
metaplasia promoted their production. Intestinal- 
ized gastric epithelium in the rat has been shown 
experimentally to transport lipid, lending support to 
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Fig 6. Light microscopic photomicrograph of case 2 showing 
normal surface epithelium and lamina propria in gastric mucosa 
following resolution of the cholestasis. H&E stain, x250. 
this concept (9). Domellof et al (6)considered these 
lipid islands to be permanent alterations in the 
gastric mucosa, because they did not change in size, 
location, or appearance during long intervals of 
observation. The importance of differentiating this 
lesion from gastric carcinoma was emphasized be- 
cause of the reported increased incidence of stomal 
cancers after gastric resection (10). 
While hyperlipidemia and cutaneous xanthomas 
are found in patients with cholestasis, a relationship 
between gastric xanthomas and cholestasis has not 
been previously described. Kimura et al (4) exam- 
ined the association of gastric xanthomas and se- 
lected disease states in 186 patients. The prevalence 
of gastric xanthomas was 28% in patients with bile 
duct obstruction and 58% in those without obstruc- 
tion. There was no correlation between serum lev- 
els of cholesterol or lipids and presence of gastric 
xanthomas, and there was no sigfilficant difference 
in the prevalence of gastric xanthomas in patients 
with or without cholestasis. The C tose relationship 
of gastric xanthomas to cholestasis in our cases is 
Strong evidence for a cause-and-effect relationship. 
In the  first case, gastric xanthomas disappeared 
with progressive hepatic failure, while in the second 
case, appearafice and disappearance were closely 
correlated with the course of diphenylhydantoin- 
induced hepatotoxicity. In both cases, disappear- 
ance of xanthOmas was associated with normaliza- 
tion of serum cholesterol and lipid levels. 
We believe that these two patients represent the 
first reported cases of cholestasis associated gastric 
xanthomas. The course in these patients points to 
the fact that these lipid islands may be temporary 
mucosal changes, possibly related to elevated se- 
rum cholesterol and lipid levels, and may disappear 
with resolution of cholestasis. 
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